Magnificent overview by dr Weber at
#LupusAcademy2025 on diverse manifestations of CV disease in #Lupus, including athersclerosis, pericarditis, heart failure and microvascular dysfunction. Multimodality imaging can improve screening, detection and monitoring of cardiac function. #cardiorheum

Association Between Rheumatoid Arthritis and the Risk of Incident Degenerative Valvular Heart Disease: Evidence From a Prospective Cohort Study | Journal of the American Heart Association

Interesting study in @ahajournals.bsky.social
showing higher risk of aortic stenosis, aortic regurgitation, and mitral regurgitation in #rheumatoidarthritis. Women and younger patients exhibiting higher risks. Similar findings reported in #lupus and #scleroderma. #cardiorheum

ahajrnls.org/4fVia1A

Atherosclerotic cardiovascular disease in systemic lupus erythematosus: from preclinical lupus to atherosclerotic plaque erosion Abstract. Patients with systemic lupus erythematosus (SLE) have increased risk of developing atherosclerotic cardiovascular disease (ASCVD). This excessive

In our latest publication we highlight #atherosclerosis is already enhanced before the actual SLE diagnosis (diagnostic delay). Moreover #cardiovascular disease in #lupus is associated with an adverse outcome (including recurrent events and mortality). #cardiorheum

academic.oup.com/rheumap/arti...

#Pericarditis has a high recurrence rate in #Lupus (20%), especially in younger patients (<40yrs). Use of prednisone >20mg is associated with a high recurrence rate, in a dose-dependent matter. Yet another reason to limit GC exposure. #EULAR2025 #CardioRheum

Very excited to discuss #atherosclerosis and #cardiovascular disease in #Rheumatology at #EULAR2025. Patients with #Lupus and #rheumatoidarthritis may be prone to develop plaque erosion. #CardioRheum #Rheumsky

Very interesting Hot topics in cardio-rheumatology session at #EULAR2025 with prof. Nurmohamed, Atzeni and Alunno. Risk management guidelines are available, implementation stays behind. Discussed strategies to improve this. #CardioRheum #Lupus #rheumatoidarthritis

Good to see more emphasis on the role of glucocorticoids in MACE. Important for future trial designs protocols when looking at the impact of #rheum therapeutics on ASCVD. #CardioRheum #Cardiology #Rheumatology